TIG Advisors, LLC Form 8.3 - UDG Healthcare plc - Replacement (4317C)
18 June 2021 - 11:11PM
UK Regulatory
TIDMUDG
RNS Number : 4317C
TIG Advisors, LLC
18 June 2021
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing TIG Advisors, LLC
(Note 1)
Company dealt in UDG Healthcare plc
==================
Class of relevant security Ordinary shares
to which the dealings
being disclosed relate
(Note 2)
==================
Date of dealing Please see below
==================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities N/A N/A N/A N/A
=================== =====================
(2) Derivatives (other 3,022,542 1.20% N/A N/A
than options)
=================== =====================
(3) Options and agreements N/A N/A N/A N/A
to purchase/sell
=================== =====================
Total 3,022,542 1.20% N/A N/A
=================== =====================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities N/A N/A N/A N/A
=================== =====================
N/A N/A N/A N/A
(2) Derivatives (other
than options)
=================== =====================
N/A N/A N/A N/A
(3) Options and agreements
to purchase/sell
=================== =====================
Total N/A N/A N/A N/A
=================== =====================
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(b) Derivatives transactions (other than options transactions)
Date of Product Nature of transaction Number of Price per
dealing name, (Note 6) relevant securities unit
e.g. CFD (Note 7) (Note 5)
9 June CFD Increasing a long 1,472 1049.25 gbp
2021 position
========= ===================== ==================== ===========
9 June CFD Increasing a long 2,224 1049.50 gbp
2021 position
========= ===================== ==================== ===========
9 June CFD Increasing a long 600,000 1050.41 gbp
2021 position
========= ===================== ==================== ===========
10 June CFD Increasing a long 200,000 1048.00 gbp
2021 position
========= ===================== ==================== ===========
16 June CFD Increasing a long 7,005 1047.00 gbp
2021 position
========= ===================== ==================== ===========
16 June CFD Increasing a long 231,017 1047.43 gbp
2021 position
========= ===================== ==================== ===========
16 June CFD Increasing a long 50,000 1045.00 gbp
2021 position
========= ===================== ==================== ===========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to
the
voting rights of any relevant securities under any option
referred to on this form or relating to
the voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If
none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 17 June 2021
Contact name Michael Fastert
===============
Telephone number +1 212 396 8698
===============
If a connected EFM, name N/A
of offeree/offeror with
which connected
===============
If a connected EFM, state N/A
nature of connection (Note
10)
===============
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEFPMTTMTIBBJB
(END) Dow Jones Newswires
June 18, 2021 09:11 ET (13:11 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2024 to May 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From May 2023 to May 2024